CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.verified

CNSP

Price:

$6.51

Market Cap:

$3.74M

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas...[Read more]

Industry

Biotechnology

IPO Date

2019-11-08

Stock Exchange

NASDAQ

Ticker

CNSP

The PE Ratio as of December 2025 (TTM) for CNS Pharmaceuticals, Inc. (CNSP) is 0.01

According to CNS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.01. This represents a change of -100.37% compared to the average of -2.68 of the last 4 quarters.

CNS Pharmaceuticals, Inc. (CNSP) Historical PE Ratio (quarterly & annually)

How has CNSP PE Ratio performed in the past?

The mean historical PE Ratio of CNS Pharmaceuticals, Inc. over the last ten years is -1086387.38. The current 0.01 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), CNSP's PE Ratio was at its highest in in the September 2025 quarter at -0.02. The PE Ratio was at its lowest in in the September 2018 quarter at -4844053.58.

Quarterly (TTM)
Annual

Average

-1086387.38

Median

-108091.25

Minimum

-7110698.09

Maximum

-1.54

CNS Pharmaceuticals, Inc. (CNSP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CNS Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 64.78%

Maximum Annual PE Ratio = -1.54

Minimum Annual Increase = -99.99%

Minimum Annual PE Ratio = -7110698.09

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.54-99.99%
2023-12581.2818.07%
2022-10655.68-82.68%
2021-61536.08-60.21%
2020-154646.43-81.47%
2019-834538.7464.78%
2018-506441.19-92.88%

CNS Pharmaceuticals, Inc. (CNSP) Average PE Ratio

How has CNSP PE Ratio performed in the past?

The current PE Ratio of CNS Pharmaceuticals, Inc. (CNSP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-7746.17

5-year avg

-47884.20

10-year avg

-1086387.38

CNS Pharmaceuticals, Inc. (CNSP) PE Ratio vs. Peers

How is CNSP’s PE Ratio compared to its peers?

CNS Pharmaceuticals, Inc.’s PE Ratio is greater than Windtree Therapeutics, Inc. (-0.00), greater than Pasithea Therapeutics Corp. (-0.00), greater than NLS Pharmaceutics AG (-0.68), greater than Soligenix, Inc. (-0.50), greater than Oragenics, Inc. (-0.00), greater than 60 Degrees Pharmaceuticals, Inc. (-0.45), greater than Clearmind Medicine Inc. (-0.14), greater than Ensysce Biosciences, Inc. (-0.43), greater than GRI Bio, Inc. (-0.47), greater than Silo Pharma, Inc. (-0.83),

Build a custom stock screener for CNS Pharmaceuticals, Inc. (CNSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CNS Pharmaceuticals, Inc. (CNSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CNS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is CNS Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for CNS Pharmaceuticals, Inc. (CNSP)?

What is the highest PE Ratio for CNS Pharmaceuticals, Inc. (CNSP)?

What is the 3-year average PE Ratio for CNS Pharmaceuticals, Inc. (CNSP)?

What is the 5-year average PE Ratio for CNS Pharmaceuticals, Inc. (CNSP)?

How does the current PE Ratio for CNS Pharmaceuticals, Inc. (CNSP) compare to its historical average?